Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet

PHASE3CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

April 4, 2018

Primary Completion Date

July 17, 2019

Study Completion Date

July 17, 2019

Conditions
Hypertensive Patients With Dyslipidemia
Interventions
DRUG

CKD-330

CKD-330 Tab.

DRUG

Placebo of CKD-330

Placebo of CKD-330 Tab.

DRUG

D086

D086 Tab.

DRUG

Placebo of D086

Placebo of D086 Tab.

DRUG

D723

D723 Tab.

DRUG

Placebo of D723

Placebo of D723 Tab.

Trial Locations (16)

Unknown

Dong-A University Hospital, Busan

Pusan National University Hospital, Busan

Chonnam National University Hospital, Gwangju

Gachon University Gil Hospital, Incheon

Catholic University Seoul St. Mary's Hospital, Seoul

Hanyang University Hospital, Seoul

Kangbuk Samsung Hospital, Seoul

Korea University Anam Hospital, Seoul

Korea University Guro Hospital, Seoul

Kyunghee University Hospital, Seoul

Samsung Medical Center, Seoul

Seoul Asan Medical Center, Seoul

Seoul Medical Center, Seoul

Yonsei University Medical Center Gangnam Severance Hospital, Seoul

Yonsei University Medical Center Severance Hospital, Seoul

Wonju Severance Christian Hospital, Wŏnju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY